The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Type I Interferon Receptors: Biochemistry and Biological Functions
Open accessAbstract
The type I interferon (IFN) 2The abbreviations used are: IFN, interferon; IFNAR, type I IFN receptor; IFNGR, type II IFNγ receptor; hu, human; hCR, helical cytokine receptor; ECD, extracellular domain; FBN, fibronectin; TF, tissue factor; SD, subdomain; PDB, Protein Data Bank; IL, interleukin; aa, amino acid(s); s (sIL, sIFN), soluble; JAK, Janus kinase; STAT, signal transducers and activators of transcription. receptor (IFNAR) is comprised, as other cytokine receptors, of multiple components, in this case designated IFNAR1 and IFNAR2. However it is unique among cytokine receptors in the number of cognate ligands, including 13 IFNα subtypes, β, ω, ∊, κ, and others in some species. The type I IFN receptors are distinct from those required for the type II IFNγ (IFNGR1 and IFNGR2) and type III IFNs (IFNLR and IL10Rβ). Nevertheless, genes encoding a component of each type of IFN receptor, namely IFNAR1, IFNAR2, IFNGR2, and IL10Rβ, are located on human chromosome 21q22.1 in a cytokine receptor gene cluster, as typical of functionally related genes. Although IFNs were identified 50 years ago and the existence of IFN receptors 10 years later, it was in 1990 when the first type I IFN receptor, now designated IFNAR1, was cloned. This was achieved utilizing human gene libraries expressed in murine cells and rescue of the definitive, species specific antiviral activity of human IFNα8 (1Uze G. Lutfalla G. Gresser I. Cell. 1990; 60: 225-234Abstract Full Text PDF PubMed Scopus (513) Google Scholar). IFNAR2 cloning was achieved first by identifying a human IFN binding activity in urine, peptide sequencing, and then by gene library screening with derived oligonucleotides (2Novick D. Cohen B. Rubinstein M. Cell. 1994; 77: 391-400Abstract Full Text PDF PubMed Scopus (585) Google Scholar). It was subsequently discovered that the original cDNA encoded only one isoform of the IFNAR2 gene, which also encoded a long transmembrane isoform that transduced a signal, a truncated transmembrane isoform, and a soluble/secreted isoform (3Lutfalla G. Holland S.J. Cinato E. Monneron D. Reboul J. Rogers N.C. Smith J.M. Stark G.R. Gardiner K. Mogensen K.E. EMBO J. 1995; 14: 5100-5108Crossref PubMed Scopus (227) Google Scholar) (Fig. 1A). Subsequently, the functions of the type I IFN receptors have been elucidated with respect to ligand interaction, mechanisms of signal transduction, and biological responses. The pioneering studies that discovered IFNARs and their mechanisms of actions in vitro have been largely validated in vivo using genetargeted mice. This body of work has highlighted the important roles of IFNARs in mediating type I IFN responses in hemopoiesis and innate and acquired immunity to infection and cancer. However, IFNs elicit many biological effects that can even be opposite in different cell types. For example, type I IFN inhibits proliferation and is proapoptotic for many cell types (4Platanias L.C. Nat. Rev. Immunol. 2005; 5: 375-386Crossref PubMed Scopus (2372) Google Scholar), yet it prolongs the survival of memory T cells (5Tough D.F. Sun S. Zhang X. Sprent J. Immunol. Rev. 1999; 170: 39-47Crossref PubMed Scopus (93) Google Scholar). Understanding the function of the IFNAR complex will elucidate how such a diversity of biological outcomes is generated. The IFNAR genes encode multiple isoforms that contribute to the potential complexity of the functional receptor (2Novick D. Cohen B. Rubinstein M. Cell. 1994; 77: 391-400Abstract Full Text PDF PubMed Scopus (585) Google Scholar, 3Lutfalla G. Holland S.J. Cinato E. Monneron D. Reboul J. Rogers N.C. Smith J.M. Stark G.R. Gardiner K. Mogensen K.E. EMBO J. 1995; 14: 5100-5108Crossref PubMed Scopus (227) Google Scholar, 6Owczarek C.M. Hwang S.Y. Holland K.A. Gulluyan L.M. Tavaria M. Weaver B. Reich N.C. Kola I. Hertzog P.J. J. Biol. Chem. 1997; 272: 23865-23870Abstract Full Text Full Text PDF PubMed Scopus (52) Google Scholar). Two splice variants of IFNAR1 have been identified in cell lines (7Abramovich C. Ratovitski E. Lundgren E. Revel M. FEBS Lett. 1994; 338: 295-300Crossref PubMed Scopus (29) Google Scholar, 8Cook J.R. Cleary C.M. Mariano T.M. Izotova L. Pestka S. J. Biol. Chem. 1996; 271: 13448-13453Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar). However, subsequent bioinformatic analyses of splice variants in expressed sequence tag (EST) data bases and rapid amplification of cDNA ends (3Lutfalla G. Holland S.J. Cinato E. Monneron D. Reboul J. Rogers N.C. Smith J.M. Stark G.R. Gardiner K. Mogensen K.E. EMBO J. 1995; 14: 5100-5108Crossref PubMed Scopus (227) Google Scholar′-RACE) analyses from normal cells identified only one isoform, suggesting that the former are either artifacts or aberrant transcripts found only in particular tumor cell lines. 3S. A. Samarajiwa and P. J. Hertzog, unpublished data. In contrast, four IFNAR2 transcripts encoding three isoforms are generated from the same gene by exon skipping, alternative splicing, and differential u
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
The human interferon $alpha;/$beta; receptor: Characterization and molecular cloning
NOVICK, D. (1994) · Cell · doi:10.1016/0092-8674(94)90154-6 · Cited by 667
Uzé, G., Lutfalla, G., & Gresser, I. (1990) · Cell · doi:10.1016/0092-8674(90)90738-z · Cited by 574
Symons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Malakhova, O. A., Kim, K., Luo, J., Zou, W., Kumar, K. S., Fuchs, S. Y., Shuai, K., & Zhang, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601149 · Cited by 431
Converting IL-15 to a superagonist by binding to soluble IL-15Rα
Rubinstein, M. P., Kovar, M., Purton, J. F., Cho, J.-H., Boyman, O., Surh, C. D., & Sprent, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600240103 · Cited by 416
Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., & Kola, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11284 · Cited by 377
Self-citationYou, M., Yu, D.-H., & Feng, G.-S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2416 · Cited by 364
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Rusinova, I., Forster, S., Yu, S., Kannan, A., Masse, M., Cumming, H., Chapman, R., & Hertzog, P. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1215 · Cited by 878
Self-citationDirect Effects of Type I Interferons on Cells of the Immune System
Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A., & Melero, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1114 · Cited by 503
Induction and function of type I and III interferon in response to viral infection
Levy, D. E., Marié, I. J., & Durbin, J. E. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.11.001 · Cited by 314
The Pathogenesis of Pterygium: Current Concepts and Their Therapeutic Implications
Chui, J., Girolamo, N. D., Wakefield, D., & Coroneo, M. T. (2008) · The Ocular Surface · doi:10.1016/s1542-0124(12)70103-9 · Cited by 276
INTERFEROME: the database of interferon regulated genes
Samarajiwa, S. A., Forster, S., Auchettl, K., & Hertzog, P. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn732 · Cited by 265
Self-citationIL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Greenhill, C. J., Rose-John, S., Lissilaa, R., Ferlin, W., Ernst, M., Hertzog, P. J., Mansell, A., & Jenkins, B. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002971 · Cited by 264
Self-citationInterferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection
Fung, K. Y., Mangan, N. E., Cumming, H., Horvat, J. C., Mayall, J. R., Stifter, S. A., De Weerd, N., Roisman, L. C., Rossjohn, J., Robertson, S. A., et al. (2013) · Science · doi:10.1126/science.1233321 · Cited by 261
Self-citationHu, X., Zhang, H., Zhang, Q., Yao, X., Ni, W., & Zhou, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02602-y · Cited by 258
HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2
Cao, J., Sun, L., Aramsangtienchai, P., Spiegelman, N. A., Zhang, X., Huang, W., Seto, E., & Lin, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815365116 · Cited by 189
Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer’s disease
Taylor, J. M., Minter, M. R., Newman, A. G., Zhang, M., Adlard, P. A., & Crack, P. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.089 · Cited by 145
“Importantly, type-1 IFNs are involved in the initiation and/or regulation of pro-inflammatory cytokines (de Weerd et al., 2007; Kawai and Akira, 2006) and without the presence of type-1 IFNs a robust innate immune response fails to manifest.”
The role of type I interferons in TLR responses
Noppert, S. J., Fitzgerald, K. A., & Hertzog, P. J. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100099 · Cited by 135
Self-citationMinter, M. R., Moore, Z., Zhang, M., Brody, K. M., Jones, N. C., Shultz, S. R., Taylor, J. M., & Crack, P. J. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0341-4 · Cited by 79
Role of dendritic cells in innate and adaptive immune response in human aging
Gupta, S. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.009 · Cited by 80
Varzaneh, F. N., Keller, B., Unger, S., Aghamohammadi, A., Warnatz, K., & Rezaei, N. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0053-0 · Cited by 62
Interferons: role in cancer therapy
Abdolvahab, M. H., Darvishi, B., Zarei, M., Majidzadeh-A, K., & Farahmand, L. (2020) · Immunotherapy · doi:10.2217/imt-2019-0217 · Cited by 50
Abortigenic but not neurotropic equine Herpes Virus 1 modulates the interferon antiviral defense.
Poelaert, K. C. K., Van Cleemput, J., Laval, K., Favoreel, H. W., Soboll Hussey, G., Maes, R. K., & Nauwynck, H. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00312 · Cited by 19
Metadata
- Authors
- de Weerd, N. A., Samarajiwa, S. A., & Hertzog, P. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 282
- Issue
- 28
- Pages
- 20053-20057
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2031423498
- Cited by
- 390
- References
- 49
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.